To provide leadership to advance the development, implementation and use of health preference research in support of health policy, the development of medical products, and patient care.


  • To foster discussions about known and novel methods to obtain preference information and to analyze health-preference data in support of standards for the use of these methods
  • To support early career researchers interested in the field of health preference research through involvement in the SIG activities
  • To facilitate the dissemination of good research practices for the methods used to collect and analyze health preferences among the HEOR community
  • To identify and highlight ways in which preference evidence can support patient care and health policy and health economics and outcomes research


Scientifically rigorous evidence on priorities and preferences is important in promoting patient-centered drug development, facilitating patient-centered outcomes research (PCOR), informing regulatory benefit-risk analysis, and conducting robust health technology assessment (HTA). Health preference research focuses on the development of instruments and other mechanisms to measure preferences for aspects of health policies, medical products, and patient care. These aspects are systematically evaluated by relevant stakeholders to determine their relative importance. The resulting measures of relative importance offer a unique way to understand the value of health-related initiatives and products. The broad array of methods and the ability to modify them allows their use for any number of research questions.


Kevin Marsh, PhD, BA, MA

Executive Director, Patient-Centered Research, Evidera Ltd
London, LON, United Kingdom

Christine Poulos, PhD, BA

Senior Economist, RTI Health Solutions
Research Triangle Park, NC, United States

Karin Groothuis-Oudshoorn, PhD

Assistant Professor, Department Health Technology and Services, University of Twente
Enschede, Netherlands

Working Groups

Key Project

Understanding Preference Heterogeneity: A survey of the state of practice


  • Marco Boeri, PhD, Senior Research Economist, RTI, Belfast, Northern Ireland, UK
  • Sebastian Heidenreich, MSc, PhD, Patient Preferences - Associate Director, Evidera, Aberdeen, Scotland, UK

Member Engagement

Webinar Co-Chairs:

  • Siu Hing Lo, PhD, Associate Director, Acaster-Lloyd Consulting, London, England, UK
  • Eline van Overbeeke, PhD, Health Economics and Outcomes Research Manager, Pfizer, Brussels, Belgium
  • Janine A. van Til, PhD, Assistant Professor, Faculty of Behavioural, Management and Social Sciences (BMS), University of Twente, Enschede, Netherlands

Journal Club Co-Chairs:

  • Dr. Riccarda Peters, BSc, MSc, PhD, Research Fellow, University of Melbourne, Melbourne, Australia
  • Dr. Yuan Zhang, MSc, PhD, Part-time Assistant Professor, Department of Health Research Methods, Evidence, and Impact, McMaster University and Senior Health Economist, Ontario Health, Toronto, Ontario, Canada
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now